Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

Women experiencing menopause later in life may face an increased risk of asthma, according to recent research highlighting the impact of hormone levels on respiratory health.

Later-onset menopause linked to higher asthma risk

With nearly half of short-acting contraceptive users preferring non-traditional sources such as telehealth and over-the-counter options, a recent study highlights evolving patient needs in contraceptive access.

Preference for alternative contraceptive sources reported by many patients

In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.

Importance of reproductive health services for adolescents during the COVID-19 pandemic

In a recent study, non-Hispanic Black patients were less likely to receive guideline-concordant care and had greater mortality rates, highlighting the potential for improved survival by optimizing receipt of timely care.

Less guideline-concordant care reported among Black breast cancer patients 

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Facebook

LinkedIn

RSS Feed

Spotlight

A Psychedelic to Treat Postpartum Depression?

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

Authors

Amer Karam, MD, discusses the role of secondary cytoreductive surgery in ovarian cancer and the need for careful patient selection, plus the results from 3 clinical trials and the key differences between these efforts.

Secondary cytoreductive surgery in recurrent ovarian cancer

Saying "obstetrician-gynecologist" is a mouthful for most people, and it's probably the most abbreviated specialty in medicine, both spoken and written. However, there doesn't seem to be a consensus on how to pronounce OB-GYN. First, is it the two-syllable "O-B" or the monosyllabic "Ob"? Second, is it "gin" or "gyne" (like "Lyme")? I wonder if you have a preference. I know I do.

Almost nobody says "obstetrician-gynecologist" when speaking about these specialist physicians. But what's the "correct" way to pronounce OB/GYN?

Is It Ob-Gin or Ob-Gyne?

A 27-year-old woman presents with an 18-month history of vulvar irritation. She is otherwise healthy except for episodes of depression. She has tried multiple agents for her condition including topical steroids, Vagisil, antibiotics, and fluconazole. She used oral steroids but developed knee pain. Tacrolimus has not helped. A biopsy revealed lichen simplex chronicus. Immunofluorescent studies were negative.

A 27-year-old woman presents with an 18-month history of vulvar irritation. She has tried multiple agents for her condition including topical steroids, Vagisil, antibiotics, and fluconazole without relief. What's your diagnosis?

Vulvar irritation in a 27-year-old woman

Expanding influenza vaccine options for pregnant women

Updated FLOBLOK label

In a recent interview, Ruth M Carrico, PhD, DNP, APRN, a family nurse practitioner and infectious diseases expert, discussed the updated FLUBLOK vaccine label to include safety in pregnant women.

Carrico expressed her excitement about the update, particularly in light of her experiences treating pregnant women who have developed influenza. FLUBLOK, a recombinant influenza vaccine, has been included in Centers for Disease Control and Prevention recommendations for pregnant and expectant patients since 2016, but now has updated safety data in this population. This inclusion adds to the range of available vaccines, allowing health care providers more flexibility when recommending influenza vaccinations for this vulnerable population.

There are risks associated with influenza infection during pregnancy that providers must be aware of. Pregnant women face heightened vulnerabilities caused by physiological changes, and the consequences of influenza infection can be severe. The infection can lead to respiratory illnesses, cardiovascular issues, and, in the worst cases, pneumonia, hospitalization, or even death. The fetus may also be at risk because of these complications.

Carrico also discussed results of the study results evaluating FLUBLOK in pregnant women, highlighting that the study showed no increased risk of adverse events, such as pregnancy complications, birth outcomes, or neonatal issues, when comparing FLUBLOK to standard influenza vaccines. This is reassuring for health care providers, as it indicates that no vaccine should be withheld when influenza prevention is indicated in this population.

Carrico concluded by noting that the availability of FLUBLOK simplifies the vaccination process, particularly for patients who may have concerns, such as avoiding egg-based vaccines. Having more options allows for better patient education, encourages vaccination, and ultimately helps avoid preventable complications, particularly respiratory illnesses, in pregnant women. The broader toolkit empowers health care professionals to make stronger recommendations and ensure better patient outcomes.

Ruth M Carrico, PhD, DNP, APRN, discusses the significance of the FLUBLOK vaccine's updated label, offering pregnant patients a safe and effective alternative for influenza prevention.

Clinical

Updated FLUBLOK label expands influenza vaccine options for pregnant women

What is your diagnosis based on these images of the ovary?

Challenge your diagnostic skills with this image quiz: Is this ovarian lesion cystic in nature or something else?

Image IQ: Ovarian Cyst or Something Else?

Name this structure shown by arrows in this color Doppler image of the fetal thorax. Choose one of the following:

Challenge your diagnostic skills: Can you identify this structure in the fetal thorax?

Image IQ: Anatomy of the Fetal Heart

These are 3D ultrasound images of a 14-week fetus. What is your diagnosis?

occipital meningocele and umbilical hernia

DailyDx: 3D Images of a 14-week fetus

Chris Ryan

Articles

Latest Updated Articles